By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Puma Biotechnology 

10940 Wilshire Boulevard
Suite 600
Los Angeles  Caliornia   90024  U.S.A.
Phone: 310-443-4150 Fax: 310-443-4158


SEARCH JOBS








Company News
Puma Biotech (PBYI) Crashes After Diarrhea Risk is Linked to Breast Cancer Drug in Abstract 11/15/2016 5:45:25 AM
Puma Biotech (PBYI) Reports Third Quarter 2016 Financial Results 11/10/2016 3:05:39 PM
Puma Biotech (PBYI) Closes $172 Million Public Offering Of Common Stock 10/25/2016 10:37:12 AM
Puma Biotech (PBYI) Announces Underwriters’ Full Exercise Of Option To Purchase Additional Shares 10/21/2016 8:26:56 AM
Puma Biotech (PBYI)'s $150 Million Stock Offering May Signal to Investors That Its Breast Cancer Drug is in Trouble 10/20/2016 6:50:38 AM
Puma Biotech (PBYI) Announces Proposed Public Offering Of Common Stock 10/19/2016 12:54:48 PM
Puma Biotech (PBYI) Announces FDA Acceptance Of New Drug Application For PB272 (Neratinib) For Extended Adjuvant Treatment Of HER2-Positive Early Stage Breast Cancer 9/20/2016 11:12:55 AM
Puma Biotech (PBYI) Announces EMA Validation Of Marketing Authorization Application For PB272 (Neratinib) As Extended Adjuvant Treatment Of HER2-Positive Early Stage Breast Cancer In Europe 8/22/2016 6:08:21 AM
Puma Biotech (PBYI) Reports Second Quarter 2016 Financial Results 8/10/2016 11:15:39 AM
Puma Biotech (PBYI) Submits New Drug Application For PB272 (Neratinib) To U.S. FDA For Extended Adjuvant Treatment Of HER2-Positive Early Stage Breast Cancer 7/22/2016 9:18:01 AM
12345678910...
//-->